Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Cefazolin Prophylaxis in Knee Arthroplasty
jRCTs031250802Recruiting
- Start
- May 2026
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefazolin in knee osteoarthritis (OA). Primary endpoint: Composite perioperative safety events. Started May 2026; status: recruiting.
02
Drugs
cefazolin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCTs031250802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250802.